Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

457 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
PET of Adoptively Transferred Chimeric Antigen Receptor T Cells with 89Zr-Oxine.
Weist MR, Starr R, Aguilar B, Chea J, Miles JK, Poku E, Gerdts E, Yang X, Priceman SJ, Forman SJ, Colcher D, Brown CE, Shively JE. Weist MR, et al. Among authors: shively je. J Nucl Med. 2018 Oct;59(10):1531-1537. doi: 10.2967/jnumed.117.206714. Epub 2018 May 4. J Nucl Med. 2018. PMID: 29728514 Free PMC article.
Clinical evaluation of indium-111-labeled chimeric anti-CEA monoclonal antibody.
Wong JY, Thomas GE, Yamauchi D, Williams LE, Odom-Maryon TL, Liu A, Esteban JM, Neumaier M, Dresse S, Wu AM, Primus FJ, Shively JE, Raubitschek AA. Wong JY, et al. Among authors: shively je. J Nucl Med. 1997 Dec;38(12):1951-9. J Nucl Med. 1997. PMID: 9430476 Free article. Clinical Trial.
Initial clinical experience evaluating Yttrium-90-chimeric T84.66 anticarcinoembryonic antigen antibody and autologous hematopoietic stem cell support in patients with carcinoembryonic antigen-producing metastatic breast cancer.
Wong JY, Somlo G, Odom-Maryon T, Williams LE, Liu A, Yamauchi D, Wu AM, Yazaki P, Wilczynski S, Shively JE, Forman S, Doroshow JH, Raubitschek AA. Wong JY, et al. Among authors: shively je. Clin Cancer Res. 1999 Oct;5(10 Suppl):3224s-3231s. Clin Cancer Res. 1999. PMID: 10541368 Clinical Trial.
Pilot trial evaluating an 123I-labeled 80-kilodalton engineered anticarcinoembryonic antigen antibody fragment (cT84.66 minibody) in patients with colorectal cancer.
Wong JY, Chu DZ, Williams LE, Yamauchi DM, Ikle DN, Kwok CS, Liu A, Wilczynski S, Colcher D, Yazaki PJ, Shively JE, Wu AM, Raubitschek AA. Wong JY, et al. Among authors: shively je. Clin Cancer Res. 2004 Aug 1;10(15):5014-21. doi: 10.1158/1078-0432.CCR-03-0576. Clin Cancer Res. 2004. PMID: 15297402 Clinical Trial.
Humanization of the anti-CEA T84.66 antibody based on crystal structure data.
Yazaki PJ, Sherman MA, Shively JE, Ikle D, Williams LE, Wong JY, Colcher D, Wu AM, Raubitschek AA. Yazaki PJ, et al. Among authors: shively je. Protein Eng Des Sel. 2004 May;17(5):481-9. doi: 10.1093/protein/gzh056. Epub 2004 Aug 17. Protein Eng Des Sel. 2004. PMID: 15316127
Tailoring the pharmacokinetics and positron emission tomography imaging properties of anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragments.
Kenanova V, Olafsen T, Crow DM, Sundaresan G, Subbarayan M, Carter NH, Ikle DN, Yazaki PJ, Chatziioannou AF, Gambhir SS, Williams LE, Shively JE, Colcher D, Raubitschek AA, Wu AM. Kenanova V, et al. Among authors: shively je. Cancer Res. 2005 Jan 15;65(2):622-31. Cancer Res. 2005. PMID: 15695407 Free PMC article.
457 results